Literature DB >> 7677303

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations.

S C Gumber1, S Chopra.   

Abstract

PURPOSE: To review the available data on the association between hepatitis C virus (HCV) infection and conditions reportedly related to infection with the virus and to assess the clinical implications of these associations. DATA SOURCES: Pertinent articles were identified using the Paperchase database, which simultaneously searches the MEDLINE (1966 to present), Health (1975 to present), AIDSLINE (1980 to present), and Cancerlit databases. STUDY SELECTION: All studies for a given association were reviewed, but special attention was paid to randomized controlled trials where applicable.
RESULTS: According to the available data, HCV infection appears to be strongly associated with essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda. Evidence strongly suggests that HCV has a direct pathogenetic role in some patients with the first two conditions. The association with Mooren corneal ulcers and autoimmune thyroiditis is suggested, but more data are needed to confirm it. The data for the association between HCV infection and the Sjögren syndrome, lichen planus, and idiopathic pulmonary fibrosis remain weak. Although interferon therapy has been effective in patients with both essential mixed cryoglobulinemia and membranoproliferative glomerulonephritis, a high relapse rate has been noted in the latter condition.
CONCLUSIONS: Patients with essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda should be tested for HCV infection. Conversely, signs and symptoms of these conditions should be sought in patients with chronic HCV infection. Interferon therapy is currently recommended only for patients with symptomatic essential mixed cryoglobulinemia.

Entities:  

Mesh:

Year:  1995        PMID: 7677303     DOI: 10.7326/0003-4819-123-8-199510150-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  88 in total

Review 1.  Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.

Authors:  Gül Bahtiyar; John J Shin; Ayse Aytaman; James R Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

2.  Remission of bronchial asthma after viral clearance in chronic hepatitis C.

Authors:  Norihiko Yamamoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010.

Authors:  Robert D Allison; Xin Tong; Anne C Moorman; Kathleen N Ly; Loralee Rupp; Fujie Xu; Stuart C Gordon; Scott D Holmberg
Journal:  J Hepatol       Date:  2015-05-01       Impact factor: 25.083

4.  Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.

Authors:  Elizabeth Y Chiao; Eric A Engels; Jennifer R Kramer; Kenneth Pietz; Louise Henderson; Thomas P Giordano; Ola Landgren
Journal:  Arch Intern Med       Date:  2009-02-23

5.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Authors:  Therese Högfeldt; Crystal Jaing; Kevin Mc Loughlin; James Thissen; Shea Gardner; Abeer A Bahnassy; Baback Gharizadeh; Joachim Lundahl; Anders Österborg; Anna Porwit; Abdel-Rahman N Zekri; Hussein M Khaled; Håkan Mellstedt; Ali Moshfegh
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

7.  B cell non-Hodgkin's lymphoma in chronic hepatitis C virus patients: An interesting relationship.

Authors:  Hassan S Hamdy; Nadia A Abdelkader; Amal Mansour; Enas H Allam; Hisham M El-Wakiel; Dina Elshenawy
Journal:  Indian J Gastroenterol       Date:  2015-04-29

8.  Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

Authors:  T Piche; E Gelsi; S M Schneider; X Hébuterne; J Giudicelli; B Ferrua; C Laffont; S Benzaken; P Hastier; M L Montoya; F Longo; P Rampal; A Tran
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Carlos A Ramos; Rima M Saliba; Leandro de Pádua; Ola Khorshid; Elizabeth J Shpall; Sergio Giralt; Poliana A Patah; Chitra M Hosing; Uday R Popat; Gabriela Rondon; Issa F Khouri; Yago L Nieto; Richard E Champlin; Marcos de Lima
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

10.  Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas.

Authors:  Jorge Hurtado-Cordovi; Ashley H Davis-Yadley; Seth Lipka; Magdalene Vardaros; Huafeng Shen
Journal:  J Gastrointest Oncol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.